Debate contribution: CAR T-cell Therapy
Debate contribution by Mrs Diane Dodds on .
- MLA
- Mrs Diane Dodds
- Party at the time
- Democratic Unionist Party
- Date
- 22 September 2025
- Type
- Debate contribution
- Business
- Opposition Business
- Heading
- CAR T-cell Therapy
- Assembly identifier
- Official Report component 5124475
Read the official Assembly record
Text
First, I thank the Sherry family for being here today and, indeed, for speaking so openly about Catherine's illness and her treatment. I understand that it is an exceptionally brave thing to do. Therefore, we extend our heartfelt sympathy to Fergal, Manus, Tómas, Donal and the wider family circle. As others have said, CAR T-cell therapy is an exciting, recently developed treatment for some blood cancers in children and adults. As I understand it, and this is probably simplistic, T-cells are the blood cells of the immune system that protect the body from foreign invaders. CAR T-cell therapy reprogrammes the body's T-cells to more effectively target and destroy cancer before being infused back into the individual. It is a living drug that can grow, expand and form memory, and it potentially offers the patient lifelong protection, but it is not provided in Northern Ireland. There are arrangements with the NHS centres in Great Britain to treat patients who require CAR T-cell therapy. Minister, I would be interested if you could tell us how many patients have travelled to England against the number who might have benefited from it in the past. Action 22 of the Northern Ireland cancer strategy was to monitor the viability of providing specialist services such as CAR T-cell therapy in Northern Ireland. While the Belfast Trust has submitted a business case to the Department for the new regional haematology ward, which will have improved facilities, surely, we should not allow the perfect to be the enemy of progress, and we should try to offer the treatment more proactively and much sooner so that others can benefit from a life-saving treatment. There are significant side effects associated with CAR T-cell therapies, and people who receive the treatment will have to have a multi-professional approach. Again, Minister, we would like you to give us some more information about the clinicians who will do that. We are confident that we have world-leading cancer clinicians in Northern Ireland. We need to give them the tools and permission to get on with providing the standards that we would like to see. We have no difficulty with cross-border cooperation to enable greater ease of access to much-needed treatment, but I make no apology for saying that I want to see and we want to see — I am sure that the Assembly agrees with me —
— this life-saving treatment available here in Northern Ireland for our friends, family and community.
409 words. Text as published by the Northern Ireland Assembly.
Assessment
Jev’s structured answers met the documented threshold for “not flagged”.
- Overall probability that the activity is being used to promote, exploit or escalate an identity-based controversy: 0.03 (flagging needs at least 0.70; at or below 0.30 is not flagged).
- None of the five culture-war criteria was met (each was below 0.60).
- Assessed as legitimate policy scrutiny (0.96).
- No identity-based framing was identified (1.00).
- The overall probability was at or below the not-flagging threshold.
This is an AI-generated assessment of the text, made against published criteria. It is not a finding of fact about the MLA or their intentions. The Assembly record itself is the fact.
Jev’s structured answers
| Question | Probability | Met? |
|---|---|---|
| Identity framing | 0.03 | No |
| Sectarian or communal antagonism | 0.01 | No |
| Cultural grievance politics | 0.01 | No |
| Dog-whistle messaging | 0.02 | No |
| Controversy escalation | 0.03 | No |
| Legitimate policy scrutiny | 0.96 | Yes |
| Overall judgement | 0.03 | At or below not-flagging threshold |
| Option | Probability |
|---|---|
| No identity-based framing (chosen) | 1.00 |
| Reports or questions it | 0.00 |
| Criticises or condemns it | 0.00 |
| Adopts it | 0.00 |
| Subject | Probability |
|---|---|
| No identity-related subject | 0.82 |
| Disability (including neurodivergence and mental health), disabled people and disability or sickness benefits | 0.13 |
| Irish language, Ulster-Scots and language policy | 0.02 |
| Constitutional question, Brexit, the Windsor Framework and sovereignty | 0.01 |
| Another identity-related subject | 0.01 |
Assessed 21 October 2026 at 13:16 UTC by jev-1.13.0 (requested as typesafe/jev) under rubric 2026.10-r9, methodology 1.9.
Disagree with this assessment?
Classifications can be challenged. A person reads every challenge, and any change is recorded publicly above with its reason.